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Abstract  
This work demonstrates that high resolution transmission electron microscopy 
(HRTEM) is an essential tool to understand drug delivery performance of mesoporous 
silica materials, mainly those submitted to functionalization processes involving harsh 
conditions that may affect the mesostructure. Herein a SBA-15-type mesoporous 
material bearing ≡Si(CH2)2P(O)(OCH2CH3)2 groups was synthetized following the co-
condensation route. Then, the resulting material was treated with 37% wt. HCl to 
convert ethylphosphonate groups to ethylphosphonic acid groups. The proper 
dealkylation of ethoxy groups following acid treatment was confirmed by FTIR and CP-
MAS 1H13C solid state NMR, which indicated the presence of ≡Si(CH2)2P(O)(OH)2 
functionalities in the treated sample. Characterization of mesoporous materials by XRD 
diffraction and N2 adsorption points to well-ordered SBA-15 structures in both 
untreated and acid-treated samples. Nonetheless, a deep study by HRTEM reveals that 
the acid-treatment provokes noticeable loss of mesostructural order, only remaining 
small crystalline domains. This structural damage does not influence cargo loading but 
it severely affects the release of molecules confined into the mesopores, as concluded 
from in vitro delivery tests using cephalexin as model drug. Thus, whereas untreated 
sample showed a sustained diffusion-controlled drug release during more than 2 weeks, 
100% of the loaded drug was released only after 10 hours from treated sample. This 
abrupt burst effect cannot be explained on the basis of the existing matrix-drug 
interactions, whose nature and extension is quite similar under the release conditions for 
both samples. Thus, it can be only understood on the basis of the mesostructural damage 
revealed by HRTEM studies.  
Keywords: Silica-based mesoporous materials, functionalization, mesostructural order, 
high resolution transmission electron microscopy, drug delivery. 
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1. Introduction 
Since silica-based ordered mesoporous materials entered the drug delivery landscape 
back in 2001,[1] they have received growing attention by the scientific community.[2-
14] Mesoporous silicas are attractive drug carriers due to their outstanding properties, 
including: i) low toxicity and biocompatibility; ii) an ordered pore arrangement, with 
narrow pore size distributions that allow controlling drug loading and release kinetics; 
iii) high surface area, that provides high potential for drug adsorption; iv) great pore 
volume to house high amount of therapeutic molecules; v) a silanol-containing surface, 
which can be functionalized to achieve higher control over drug loading and release.  
Understanding drug delivery profiles from mesoporous matrices is essential to 
exploit their potential as controlled release systems. Drug release process obey four 
sequential steps:[15] penetration of the release medium into the pore network, which is 
governed by osmotic pressure derived from concentration gradients; drug dissolution in 
the release medium; drug diffusion through the porous cavities due to concentration 
gradients; and drug diffusion and convection within the delivery medium. The structural 
and textural properties of mesoporous materials together with the chemical nature of 
their surface are the driving factors that govern the release of molecules and determine 
drug delivery profiles.[2,5] Thus, pore diameter is a limiting factor for the diffusion of 
the molecules to the delivery medium, thus regulating the release rate.[1,16] Pore 
connectivity and structure also influence drug release kinetics. [17,18,20] For instance 
3D-bicontinuous cubic mesostructures allow easy fluid accessibility and fast molecular 
transport than 2D-hexagonal array of pores.[17]  However, organic modification or 
functionalization of mesoporous matrices is cornerstone in the performance of these 
materials as drug delivery systems.[2,5,19,20]  Commonly, functionalization strategies 
of mesoporous silicas rely on the covalently grafting of organic silanes ((RO)3SiR’).[21] 
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This process permits the modification of the silica surface by grafting organic groups 
selective to the chemical nature of the drug to be hosted. In most cases, organic 
modification allows increasing host-guest interaction between the mesoporous matrix 
and the drug molecule. Matrix-drug interactions are usually established through 
electrostatic or Coulombic interaction, hydrogen bonding, and apolar 
interaction,[5,22,23] offering many possibilities to control drug adsorption and release. 
Some functionalization processes require post-synthesis treatments under rather harsh 
conditions, highlighting those involving strong acids, which could affect the 
mesostructural order.[24] For instance, the treatment of SBA-15 functionalized with –
CN groups followed by treatment with 48 % wt. H2SO4 to oxidize cyanide groups to 
carboxylic acid groups (–COOH);[25,26] or the treatment of SBA-15 functionalized 
with –P(O)(OCH2CH3)2 groups followed by the treatment with 37% wt. HCl to 
dealkylate phosphonate groups to phosphonic acid groups (–P(O)(OH)2).[27] Whatever 
the functionalization method used to organically modify the surface of mesoporous 
matrices, but highlighting those involving aggressive conditions, it is indispensable to 
deeply study the properties of the resulting materials by using suitable characterization 
techniques. Actually, any alteration in the mesostructural order could strongly influence 
drug release process leading to unforeseen delivery profiles, albeit, to the best of our 
knowledge, this has not been reported yet.   
Herein we demonstrate that high resolution transmission electron microscopy 
(HRTEM) is an essential tool to understand drug release kinetics from mesoporous 
matrices. For this purpose, SBA-15 incorporating ethylphosphonate functions (– 
(CH2)2P(O)(OH)2) was synthetized by co-condensation route and then was treated with 
concentrated HCl under reflux to achieve ethylphosphonic acid moieties (– 
(CH2)2P(O)(OH)2 ). Although X-ray diffraction (XRD) and N2 adsorption studies point 
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to well-ordered 2D-hexagonal structures in both samples, in vitro drug delivery profiles 
are dramatically different, despite of exhibiting similar host-guest interactions under the 
release conditions. This behavior can be only explained if a deep characterization of 
samples by HRTEM is performed. Such study reveals that there is a noticeable loss of 
mesostructure in acid-treated sample, which would account for the rapid and 
uncontrolled drug release kinetics. 
 
2. Materials and methods 
2.1. Synthesis of Materials 
SBA-15 type mesoporous silica material containing nominal 15 mol% (based on 
silicon) phosphonic acid diethyl ester groups (SBA15DPT) was synthetized by the co-
condensation route using diethylphosphatoethyltriethoxysilane (DPT, 92%, ABCR) 
(Scheme 1). Briefly, 8.0 g of Pluronic® P123 block copolymer (PEO20PPO70PEO20) 
kindly provided by BASF Co.) was added to a mixture of 276 mL of H2O and 20.6 mL 
of concentrated HCl (37% wt., Aldrich).[28] The solution was moderately stirred at 35 
ºC until total surfactant dissolution. Then, 14.1 mL of tetraethyl orthosilicate (TEOS, 
98% wt., Aldrich) was added. After ca. 20 min a white powder appeared. Then, 3.6 mL 
of DPT previously dissolved in 18 mL of isopropanol (C3H7OH, 99.5% wt, Aldrich) 
was dropwise added to the suspension. The molar composition of the reaction mixture 
was: 0.85 TEOS: 0.15 DPT: 0.017 P123: 3.4 HCl: 208 H2O: 3.4 C3H7OH. Mixtures 
were kept under magnetic stirring at 35ºC for 24 h and then sealed in glass beakers and 
heated at 100 ºC for further 24 h. Then, the obtained products were filtered, washed 
with deionized water, and then dried at 60ºC for 24 h. Finally, the surfactant was 
removed by a previously reported solvent extraction method.[29] Briefly, 1 g of 
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material was soaked into a beaker containing 100 mL of an isooctane-ethanol (3 : 2) 
mixture (isooctane, ≥99.5% wt, Aldrich; ethanol, 95%, Panreac) and kept under 
magnetic stirring at room temperature for 48 h. Afterward, the sample was filtered and 
then subjected to a second extraction process by soaking the powder into 120 mL of an 
acetone-water (1 : 1) mixture (acetone, QP, Panreac) for 24 h at room temperature under 
magnetic stirring. After the extraction processes samples were left to dry in a vacuum 
oven at 40ºC for 24 h to ensure total solvent removal.  
Phosphonate ester groups can be transformed readily to phosphonic acid groups by 
acid-catalyzed hydrolytic dealkylation in concentrated HCl. Thus, SBA-15 type 
mesoporous silica material containing nominal 15% mol% (based on silicon) 
phosphonic acid groups (HCl-SBA15DPT) was obtained from SBA15DPT by using a 
previously reported procedure consisting on treating the SBA15DPT sample with 
concentrated HCl (Scheme 1).[27] Briefly, 0.5 g of SBA15DPT sample was refluxed in 
50 mL of concentrated HCl (37%, Aldrich) at 100ºC for 24 h. Then sample was filtered, 
gently washed with deionized water and dried at 60 ºC for 24 h. 
 
2.2. Characterization of Materials 
The structural characterization of materials was performed by powdered X-ray 
diffraction (XRD) in a Philips X’Pert diffractometer (Eindhoven, The Netherlands) 
equipped with CuKα (40 kV, 20 mA) over the range from 0.6 to 6.0º with a step of 0.02º 
and a contact time of 5 s. Electron microscopy was carried out in a JEOL 3000FEG 
transmission electron microscope operating at 300 kV and fitted with a X-ray energy 
dispersive spectrometer (EDS) (Oxford Instruments). 
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The textural properties of materials were determined by N2 adsorption porosimetry. 
The N2 adsoption/desorption analyses were carried out at -196 ºC on a Micromeritics 
ASAP2020 analyzer (Micromeritics Co., Norcross, USA). In all cases, 50-70 mg of 
material was degasses at 80 ºC for 24 h under a vacuum lower than 0.3 kPa before the 
analysis. The surface area (SBET) was determined from adsorption data obtained at P/P0 
between 0.05 and 0.2 by using the Brunauer-Emmett-Teller (BET) method.[30] The 
total pore volume was estimated from the amount of N2 adsorbed at a relative pressure 
of 0.97, assuming that adsorption on the external surface was negligible compared to 
adsorption in pores. To assess the possible existence of micropores (pore diameter < 2 
nm) in samples, the t-plot method was employed,[31] which allowed the estimation of 
the microporous fraction contributions, VµP and SµP, to the total pore volume and surface 
area, respectively. The average mesopore size (DP) was obtained from the maximum of 
the pore size distribution calculated from the adsorption branch of the isotherm using 
the BJH method.[32]  The wall thickness (twall) was calculated by using the expression 
twall = a0– DP, where a0 is the unit cell parameter calculated from the d10 value of XRD 
using the expression a0 = d10 × 2/ /√3.[33] 
The existence of functional groups and their chemical nature were investigated by 
Fourier transform infrared spectroscopy (FTIR) in a Thermo Nicolet Nexus 
spectrometer equipped with a Goldengate attenuated total reflectance (ATR) device 
(Thermo scientific, USA). Quantitative determination of phosphorus in functionalized 
samples was determined by using X-ray fluorescence spectroscopy (XRF) in a Philips 
PANanalytical AXIOS spectrometer (Philips Electronics NV). X-ray were generated 
using the RhKα line at λ = 0.614 Å. The amount of residual surfactant in samples was 
calculated from elemental chemical analysis and thermal analyses (TG and DTA). 
Elemental chemical analysis was carried out in a Perkin-Elmer 2400CHNS thermo 
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analyzer (Perkin-Elmer, USA). Thermal analyses were conducted under a dynamic air 
atmosphere between 30 and 950 ºC (flow rate 50 mL min-1 with a heating rate of 10 ºC 
min-1) using a Perkin Elmer Diamond analyzer (Perkin-Elmer, USA). 
To investigate the cross-linking degree and the amount of silanol groups present in 
the synthesized materials 29Si magic angle spinning (MAS) solid-state nuclear magnetic 
resonance (NMR) measurements were performed in a Bruker AV-400-WB spectrometer 
(Karlsruhe, Germany) operating at 79.49 MHz. Solid samples were placed in a 4 mm 
zirconia rotor and spun at 10 kHz. Chemical shifts (δ) of 29Si were externally referred to 
3-trimethylsilyl-1-propanesulfonic acid sodium salt (DDS) at δ = 0.0 ppm. Time periods 
between successive accumulations were 5 ms and ca. 15 000 scans were collected. The 
population of silanol groups per mole of silica was calculated from the relative 
population of silanol and germinal species, and divided by the weight per mol of silica 
materials (Eq. 1).[34] The weight is derived from the relative populations and effective 
molecular weights (EMW) of the silanol, germinal, and siloxane species. The effective 
molecular weight of each species (EMWQ) is defined as the sum of the molecular 
weight of the atoms contributing to each species with the oxygen atoms in the siloxane 
bridges (Si–O–Si) that connect the species counted by half. The equation is: 
[] = 
×%	%%×   (Eq. 1) 
Where [SiOH] is the silanol group concentration in mol g-1 and %Qi is the relative 
population of species Qi (Q2, Q3 and Q4). 
1H→13C and 1H→31P CP (cross-polarization)/MAS solid state NMR measurements 
were performed to evaluate the different carbon and phosphorus environments, 
respectively, in the synthesized samples. Samples were spun at 12 kHz for 13C and 6 
kHz for the case of 31P. The spectrometer frequencies were set to 75.45 and 161.97 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
9 
 
MHz for 13C and 31P, respectively. Chemical shift values were referenced to glycine and 
phosphoric acid (H3PO4) for 13C and 31P, respectively. All spectra were obtained by 
proton enhanced CP employing a contact time of 1 ms. The time period between 
successive accumulations was 3 s and 4 s for 13C and 31P, respectively, and the number 
of scans was ca. 15 000 for all spectra. 
To investigate the surface charge properties of materials in aqueous media, zeta-
potential (ζ)-measurements at different pH values were performed on a Malvern 
Zetasizer Nano Series instrument (UK). For this purpose, 5 mg of each powdered 
sample was added to 5 mL of KCl 10 mM (used as the supporting electrolyte) and the 
pH was adjusted by adding appropriate volumes of 0.10 M HCl or 0.10 M KOH 
solutions.  
 
2.3. In vitro Drug Loading and Release 
Cephalexin (CPX) was chosen as model drug for loading and release assays. CPX 
loading assays were carried out by soaking 250 mg of powder samples in 10 mL of a 20 
mM CPX solution in water (pH = 6) for 40 hours under magnetic stirring. Then samples 
were filtered, gently washed with deionized water and dried at room temperature under 
vacuum for further 24 hours. The presence of CPX in powdered samples was assessed 
by FTIR spectroscopy and the amount of drug loaded was determined by CHNS 
elemental chemical analysis.  
To carry out in vitro CPX release assays, 35 mg of each drug loaded powder sample 
was compacted into disks of 6 mm in diameter and 2 mm in height by using uniaxial 
pressure at 2.75 MPa. Then, the disks were hung in screw caps using platinum wire and 
soaked into tubes containing 2 mL of phosphate buffer saline (PBS, Sigma-Aldrich, pH 
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7.4). The solution was kept at 37 ºC and, to avoid limitations of the delivery rate by 
external diffusion constraints, continuous orbital stirring at 150 rpm was maintained 
during the assays. After certain intervals of time, samples were removed from PBS and 
placed in tubes containing 2 mL of fresh PBS. The cumulative CPX released was 
determined by UV-Vis spectroscopy by measuring the absorbance signal at 251 nm in a 
Unicam UV500 spectrometer (Gemini BV, Germany). CPX solutions in PBS with 
concentrations in the 0.01–0.2 mg mL-1 range were used for calibration. The curve was 
linear with a relationship of absorbance = 13.95 [CPX] (correlation coefficient = 0.998). 
The apparent drug release was normalized to the amount of drug loaded within the 
samples to calculate the relative amount of drug release. The CPX concentration was 
determined from the average of the readings from three different samples (N = 3), and 
data were presented as mean ± standard deviation. 
 
3. Results and Discussion 
3.1. Materials Characterization 
The chemical nature of samples was investigated by using FTIR, CHNS elemental 
chemical analysis, XRF and solid-state NMR spectroscopy. Fig.1.A displays FTIR 
spectra of samples before (SBA15DPT) and after (HCl-SBA15DPT) being submitted to the 
HCl treatment. All spectra show a broad band at around 3400 cm-1 corresponding to the 
overlapping of the O–H stretching bands of hydrogen-bonded water molecules (H–O–
H) and SiO–H stretching of surface silanols hydrogen bonded to molecular water (SiO–
H ••• OH2). The O–H bending vibration mode of these adsorbed water molecules 
account for the band centered at 1630 cm-1. In addition, the Si–O in-plane stretching 
vibrations of the silanol Si–OH groups appear at 960 cm-1, whose reasonably high 
intensity points to the relatively low polymerization degree of the silica matrices. The 
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relative intensity of this band is slightly smaller in HCl-SBA15DPT than in SBA15DPT, 
which would account to a higher condensation degree of the silica matrix in the former, 
in agreement with 29Si MAS solid state NMR studies (vide infra). The intense silicon-
oxygen covalent bond vibrations appearing in the 1100-1000 cm-1 range confirm the 
existence of a silica network, where oxygen atoms play the role of bridges between two 
silicon atoms. Besides, the symmetric stretching vibration of Si–O–Si and its bending 
mode appear at ca. 800 and 440 cm-1, respectively.[35] The band at 560 cm-1 is assigned 
to Si–O stretching of the silica network defects. 
The incorporation of ethylphosphonate groups (–(CH2)2PO(OCH2CH3)2) into SBA15DPT 
sample and their transformation to ethylphosphonic acid moieties (–(CH2)2PO(OH)2) 
after acid treatment in HCl-SBADPT sample can be confirmed by FTIR spectroscopy. 
The ≡Si–(CH2)2PO(OCH2CH3)2 fragments in SBA15DPT sample are reflected in the 
FTIR spectra as the group of three bands with moderate intensities within the 3000-
2800 cm-1 and weakly intense bands within the 1490-1350 cm-1 range (see Fig.1.B for a 
magnification of the FTIR spectrum in the 1600-1300 cm-1 region). The former are 
characteristic of asymmetric and symmetric C–H stretching vibrations, whereas the 
absorption bands at 1480 cm-1, 1450 cm-1, 1395 cm-1 and 1372 cm-1 can be respectively 
assigned to δ(CH2), δas(CH3), δs(CH3) and ω(CH2) vibrations of ethoxy groups bounded 
to phosphorus. The band with moderate intensity at 1414 cm-1 is characteristic of CH2 
vibrations related to Si-CH2 fragments.[36] The ν(P=O) absorption band appears as a 
shoulder at 1215 cm-1. The low-frequency shift compared to pure DPT (ca. 1241 cm-1) 
suggests the participation of phosphoryl groups in the formation of hydrogen bond. 
The successful conversion of –PO(OCH2CH3)2 into –PO(OH)2 groups after treatment 
of SBA15DPT sample with HCl is evidenced in the FTIR spectrum of HCl-SBA15DPT, 
which exhibit distinct differences from that of SBA15DPT (Fig.1). First, the three peaks 
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at 3000-2800 cm-1attributed to C-H vibrations become very weak. In addition, the bands 
in the 1490-1350 cm-1 region related to vibration modes of ethoxy groups bonded to 
phosphorus site of DPT almost completely disappear. Only the band at 1414 cm-1 
related to –Si(CH2)2–P– fragments is clearly observed.  
XRF analyses provided the phosphorus content in samples, which allowed 
determining the number of functional groups present in samples, being 1.5 and 2.5 the 
density of ≡Si–(CH2)2PO(OCH2CH3)2 and ≡Si–(CH2)2PO(OH)2 groups per nm2 for  
SBA15DPT and HCl-SBA15DPT samples, respectively (Table 1). These findings are in 
good agreement with the nominal values of 1.7 and 2.3 functional groups per nm2 for 
SBA15DPT and HCl-SBA15DPT samples, respectively, which have been calculated on the 
basis of the 0.85/0.15 TEOS/DPT nominal molar ratio used during the synthesis and 
taking into account the experimental surface areas (SBET, Table 1). CHNS elemental 
analyses allowed determining the amount of residual surfactant in samples, being 4.2% 
and 0.3% in SBA15DPT and HCl-SBA15DPT, respectively, which accounts for the almost 
complete template removal in the latter aided by the acid treatment. 
The nature and status of phosphonate groups in samples was also investigated by solid 
state NMR spectroscopy. 1H → 13C CP-MAS solid state NMR was used to confirm the 
presence of organic functional moieties and the removal of surfactant from samples. In 
this work it is also a valuable tool to determine if the ethoxy groups on the phosphorus 
sites of DPT are hydrolyzed after the HCl treatment and therefore phosphonate groups 
from DPT in SBA15DPT are converted to phosphonic acid groups in HCl-SBA15DPT. As 
expected, signals attributed to the residual surfactant are found in the 1H  13C NMR 
spectrum of SBA15DPT (indicated by asterisks in Fig.2), in agreement with the results 
derived from elemental chemical analyses. In the 1H  13C CP-MAS NMR spectrum of 
SBA15DPT two intense resonances at 5.9 and 20.0 ppm represent the ethyl carbon atoms 
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C1 and C2, which are those linked directly to silicon (–Si–CH2–CH2–P–) and 
phosphorus (–Si–CH2–CH2–P–), respectively.[36,37] The 1H  13C CP-MAS NMR 
spectrum of SBA15DPT sample displays another two well-defined peaks at 65.0 and 17.8 
ppm respectively assigned to α and β carbons of ethoxy groups on the phosphorus site 
of the phosphonate groups. After treatment with HCl, the almost total disappearance of 
such resonances in the NMR spectrum confirms that practically all the ethoxy groups 
have been successfully converted to hydroxyl groups in HCl-SBA15DPT (Fig. 2). 
1H → 31P CP-MAS solid state NMR spectra of samples (Fig. 3) display two main peaks 
centered at around 33 and 22 ppm, which indicate that there are two distinct local 
environments of the 31P nuclei. The peak appearing at 33.5 ppm in SBA15DPT slightly 
shifts towards upfield (31.5 ppm) in HCl-SBA15DPT spectrum, which can be attributed 
to the transformation of phosphonate (PO(OEt)2) to phosphonic acid (PO(OH)2 or 
PO(OH)(OEt)) groups.[38] The peak appearing at ca. 22 ppm in both samples is a 
consequence of surface interactions between the phosphorus containing groups and the 
silica framework, i.e. formation of hydrogen bond with the silanol groups (Si–OH) 
present in the silica matrix.[37] The intensity ratios for the ca. 32 peak to the 22 ppm 
peak are 93:7 and 73:27 for SBA15DPT and HCl-SBA15DPT, respectively, suggesting and 
increase in the number of phosphonic acid groups that are engaged in hydrogen bonding 
after treatment with HCl.  
To evaluate the chemical grafting of organosiloxane to the silica network and the 
silica condensation degree, 29Si MAS-NMR spectroscopy measurements were carried 
out. Tetra-functional silicon centers were named with the conventional Qn notation, 
where Q refers to [(SiO)nSi(OX)4-n] units, n being the number of bridging oxygen atoms 
surrounding the central silicon atom and X = H or CH2CH3. Likewise, tri-functional 
silicon centers were named with the conventional Tm notation, where T refers to 
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[(SiO)mRSi(OX)3-m] units, m being the number of bridging oxygen atoms surrounding 
the central silicon atom, X = H or CH2CH3 and R = –(CH2)2–PO(OCH2CH3)2 or ≡Si–
(CH2)2–PO(OH)2. The relative populations of silicon environments were calculated by 
deconvolution of the 29Si NMR spectra into individual Gaussian peaks. The assignation 
of the resonance signals from the spectra is displayed Fig. 3 and the relative peak areas 
are shown in Table 2. All spectra display five signals at ca. -94, -103 and -113 ppm, 
corresponding to Q2, Q3 and Q4 species, and at ca. -62 and -69, corresponding to T2 and 
T3 sites, at the relative intensities displayed in Table 2. The presence of these two latter 
signals confirms the existence of covalent bonds between the silica surface and the 
organic groups. From the normalized peak areas, the relative abundance of Tm species 
the molar functionalization degree, %F = Tm/(Tm+Qn), can be calculated, being 15% and 
12% for SBA15DPT and HCl-SBA15DPT samples, respectively, in close agreement with 
the nominal one  based on the composition of the initial mixture (15%). For HCl-
SBA15DPT higher Q4/Q3 values are obtained (Table 2), which is associated to a 
significant decrease in the intensity of Q3 and Q2 species. Actually, there is a 16% 
increase in the relative intensity of Q4 species in HCl-SBA15DPT sample compared to 
SBA15DPT material, in agreement with the decrease with the number of silanol groups 
and therefore and increase in the silica condensation degree of the former. These 
findings agree with the results derived from FTIR, where the relative intensity of the 
vibration bands ascribed to silanol groups decreased in the spectra of acid-treated 
sample. Previous reports have demonstrated that two pathways could contribute to the 
increase in the intensity of the Q4 species after treatment with HCl.[38] One is the 
formation of cyclic P–O–Si (Q4) resulting from the side reaction of PO3H2 groups and 
neighboring Q2 and/or Q3 groups, and the other is the further condensation of Q2 and Q3 
silanols.  
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Once investigated the chemical nature of samples, their structural characterization 
was carried out. XRD patterns at small angles of SBA15DPT and HCl-SBA15DPT 
samples display well resolved peaks at 1:31/2:2 d-spacing ratios (Fig. 4), which can be 
indexed as 120, 110 and 210 reflections, respectively of a well-ordered 2D-hexagonal 
structure with p6mm plain groups typical of SBA-15. The increase of d(100) spacing in 
HCl-SBA15DPT compared to that in SBA15DPT indicates the lattice expansion of the 
material after being submitted to the HCl reflux. This phenomenon has been previously 
reported for other mesoporous organosilicas functionalized with phosphonate moieties 
and treated with concentrated HCl.[39] 
Fig.5.A displays the N2 adsorption-desorption isotherms of samples. Both of them 
can be identified as type IV isotherms, according to the IUPAC classification, with clear 
H1-type hysteresis loops at relative high pressure that indicate the existence of open-
ended cylindrical mesopores with narrow pore size distributions, which are 
characteristic of SBA-15 type materials.[31,33] The main textural features derived from 
the appropriate treatment of N2 adsorption data are summarized in Table 1. It should be 
noticed that the surface area (SBET) of HCl-SBA15DPT sample (364 m2/g) experiences a 
decrease of 25% with respect to that of SBA15DPT (466 m2/g). The total pore volume 
(VP) is preserved, being ca. 5 cm3/g for both samples, although there is a decrease in the 
micropore volume in HCl-SBA15DPT. The pore diameters (DP) are 7.4 and 8.7 nm for 
SBA15DPT and HCl-SBA15DPT, which points to and enlargement of the mesopore size 
and a broadening in the pore size distribution of the material after the acid treatment 
(Fig. 5.B). Nonetheless, as the network lattice (a0) also experiences an expansion after 
the HCl reflux, the wall thickness (twall) remains constant, ca. 5 nm, for both materials. 
XRD and N2 adsorption porosimetry studies indicate that even after being submitted 
to the relative harsh acidic conditions, HCl-SBA15DPT sample preserves the well-
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ordered 2D hexagonal structure typical of SBA-15, whereas only exhibits slight 
modifications in its textural properties compared to SBA15DPT. Accordingly, HCl-
SBA15DPT shows slightly smaller surface area (SBET), micropore area (SµP) and 
micropore volume (VµP), and greater pore diameter than SBA15DPT sample.  
 
3.2. In vitro drug loading and release  
To investigate the performance of both matrices as drug delivery devices, their 
adsorption and release behavior was in vitro evaluated using cephalexin (CPX) as 
model drug. Loading assays were carried out by soaking powdered samples in water 
(pH ∼ 6), and CPX release experiments were carried out at the physiological pH of 
7.4.[40] In the aqueous medium the CPX molecule exhibit different ionization states 
depending on the pH, which is due to the presence of one carboxylic acid group and one 
amine group into its structure (Fig. 6).  
With the aim of understanding the interaction of CPX with the different mesoporous 
samples, the possible ionization equilibria in aqueous media and their corresponding 
constants depending on the grafted functional groups are displayed below: 
–Si–OH + H2O –Si–O– + H3O+  (Eq. 2) 
(deprotonation of Q3 silanol groups pKa ∼2-4.5, ref. [41]) 
–Si–OH + H2O  –Si–O– + H3O+ (Eq. 3) 
(deprotonation of Q2 silanol groups pKa∼8.5, ref. [41]) 
–PO3H2 + H2O  –PO3H– + H3O+ (Eq. 4) 
(1st deprotonation of phosphonic acid groups pKa ∼ 2-3; ref. [42]) 
–PO3H– + H2O  –PO32– + H3O+  (Eq. 5) 
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(2nd deprotonation of phosphonic acid groups pKa ∼ 7-8; ref. [42]) 
To get information about the net surface of mesoporous materials, ζ-potential 
measurements were recorded at different pH values, being ca. -32 mV and ca. -36 mV 
the values respectively found at pH of 6 and 7.4 for both samples. The similar ζ-
potential found values can be explained by the almost equal number of ionizable –OH 
groups present in both materials, which provide the surface of samples of Brönsted acid 
character (Table 1). SBA15DPT sample exhibit 10.6 -SiOH per nm2. On the other hand, 
HCl-SBA15DPT possesses lower number of –SiOH (9.0 per nm2) but it also exhibits 2.5 
ionizable –PO3H2 groups per nm2. These organic groups are responsible of the net 
negative charge present in the materials both at the loading and the release pH.  
The amount of CPX loaded into mesoporous samples was quantified by elemental 
chemical analyses, being 21.9 and 39.0 mg/g for SBA15DPT and HCl-SBA15DPT 
samples, respectively (Table 3). As previously mentioned, the main forces that govern 
the adsorption of molecules on mesoporous silicas are electrostatic or Coulombic 
interactions, hydrogen bonding and non-polar interactions.[43] In this particular case, 
non-polar interactions are not the driving forces, because both CPX and the matrices 
synthesized in this work possess a principally hydrophilic character. At the loading pH 
of 6, ca. 86% of CPX is found as zwitterionic specie (CPX±), where the amino group is 
protonated as –NH3+ and the carboxylic acid group is deprotonated as –COO–. Thus, 
only 14% of CPX molecules would exist as positive charge species. Therefore, different 
electrostatic attracting interactions and H-bonding take place between CPX and both 
SBA15DPT and HCl-SBA15DPT materials. The protonated amino group (–NH3+) from 
zwitterionic CPX± is capable of interacting with deprotonated silanol groups (SiO–) 
present in the mesoporous walls. Besides, this –NH3+ group (hydrogen bond donating 
group) can also interact via hydrogen bonding with phosphoryl group (–P=O) (hydrogen 
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bond accepting group). Finally, protonated carboxylic groups (–COOH) of CPX+ can 
form hydrogen bonds with -SiO- and P=O groups of mesoporous samples. In the case of 
HCl-SBA15DPT sample there are additional host-guest interactions that cannot take 
place in SBA15DPT, namely: i)electrostatic attracting interactions between –NH3+ (from 
CPX± and CPX+) and deprotonated phosphonic acid groups (–PO-); and ii) hydrogen 
bonding between NH3+ (from CPX± and CPX+) and phosphonic acid group (–P–OH), 
between deprotonated carboxylic groups from CPX± and –P–OH on materials surface, 
and carboxylic groups (–COOH) from CPX+ and –PO– from mesoporous samples. The 
extra matrix-drug interactions between CPX and HCl-SBA15DPT compared to those 
existing in SBA15DPT would account for the greater drug loading in the former, as 
experimentally found, despite of presenting lower SBET.  
In vitro drug release assays were performed in PBS under physiological conditions 
(pH 7.4 and 37 ºC). Fig. 7 shows CPX release patterns from both mesoporous matrices. 
The main driving force that usually governs drug departure from mesoporous matrices 
is pore diffusion/convection, which can be fitted to first order kinetics.[29,44]   In 
addition, the carrier-drug host-guest interactions play a key role in drug release kinetics 
from mesoporous materials. In this sense, drug molecules may directly interact with 
mesoporous matrices, lowering their solubility and/or retaining their release. In such a 
case, drug molecules are termed as associated, which need to be disassociated from 
nanocarriers prior to release. The association and dissociation processes are assumed to 
be reversible and also follow first order kinetics. Therefore, the theoretical model 
adopted in this work considers both first-order diffusion/convection and drug 
association/dissociation processes.[44] Then, the drug release mechanism can be 
described by the following equation:  

 =
  
!  
1 − $
%&' + !!  1 − $
%  '        (Eq. 6) 
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where Mt is the cumulative drug release at time t; M0 is the initial amount of drug; ks is 
the rate constant of diffusion/convection; and kon and koff are the rate constants of 
association and disassociation, respectively. The free energy difference between the free 
and bound states, ∆G, determines the amounts of initially free and bound drug, and can 
be calculated by the equation: 
∆G	 = +,-./ 0 !  1  (Eq. 7) 
where, kB is the Boltzmann’s constant and T is the absolute temperature (assumed to be 
310 K). In this study, therefore, three parameters, ∆G (instead of kon), ks and koff were 
used to describe the cumulative drug release from mesoporous silica materials.  
CPX release from SBA15DPT is characterized by a high initial burst release (> 30%) 
followed by a steady-state release, which corresponds to category III of drug release 
profiles classification reported by Ye et al.[45] The fit of the experimental CPX release 
patterns from SBA15DPT to Eq. 5 allows determining the experimental values for ks, kon 
and koff. Then ∆G was calculated using Eq. 7. The obtained results, which properly fit to 
the theoretical model (R2= 0.9995), are summarized in Table 3. The conditions ks>>koff 
and ks>>kon are fulfilled, which indicates that diffusion and convection are not neglected 
during the steady-state release.  
At the physiological pH of 7.4, mainly repulsive host-guest interactions take place 
between SBA15DPT and CPX. Actually, at such pH, 80% CPX exist in its anionic 
species (CPX-), whereas only 20% is present as the zwitterionic molecule (CPX±). The 
surface of mesoporous material is negatively charged (ζ-potential = -36 mV), which 
lead to repulsive electrostatic interactions between deprotonated silanol groups (–SiO-) 
in SBA15DPT and CPX- bearing –COO- groups. This leads to a relative high initial burst 
release, where ca. 50% of drug is released during the first 10 hours of assay, which 
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accounts for the weak CPX-mesoporous matrix association and is in agreement with the 
positive ∆G value of 0.3× 10-21J. This burst release may occur to equilibrate the 
concentrations in both the release medium and the matrix, albeit it has been also 
ascribed to the release of the molecules adsorbed in the outer surface of mesoporous 
matrices [19,20]. ks provides information about the rate of diffusion/convection, but not 
about the magnitude of the initial burst release. The model reveals a ks value of 0.98 h-1 
for SBA15DPT, which accounts for a moderated diffusivity of the drug confined into the 
mesoporous channels. The carrier-drug host-guest interactions can be related to the koff 
value, which is 5.7 × 10-23 h-1. The koff value gives information about the steady release 
following initial burst release, but has no effect on the magnitude of initial burst release. 
Once the CPX concentration inside mesopores decreases obeying a burst effect, a 
sustained steady-state release where 93% of CPX is released after 2 weeks of assay 
occurs.  
In principle, CPX release profile from HCl-SBA15DPT mesoporous material would be 
expected to be similar to that of SBA15DPT. This would be supported by the fact that the 
number of Brönsted acid groups susceptible of undergoing deprotonation is similar, ca. 
5×10-21 groups per gram of material, in both cases  (Table 1), being 4.9×10-21  –SiOH 
per gram of material for SBA15DPT and 3.3 × 10-21 –SiOH and 1.8 ×10-21 –POH  per 
gram for HCl-SBA15DPT. This also agrees with the ζ-potential values determined for 
both samples at pH 7.4 of ca. -36 mV, which would account for repulsive electrostatic 
host-guest matrix-CPX interactions for both samples. On the other hand, XRD patterns 
of both materials pointed to a well-ordered 2D-hexagonal p6mm structure typical of 
SBA-15. Moreover, the results derived from the treatment of N2 adsorption data only 
evidenced slight variations in the textural properties of both materials (Table 1). The 
slightly greater pore diameter of HCl-SBA15DPT (8.7 nm) compared to that of 
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SBA15DPT (7.4 nm) could account for a relative higher drug diffusivity of the former. In 
addition, the relative higher microporosity of SBA15DPT (SµP = 35 m2/g) compared to 
that of HCl-SBA15DPT (SµP = 18 m2/g) could also contribute to a slower drug release out 
of the pores in the former. In this sense, drug molecules would be expected to have 
stronger interactions with the host in the sequestered volume provided by the 
micropores, which would lead to more sustained release kinetics.[46] 
Even though taking into consideration the above-mentioned aspects, drug release profile 
of HCl-SBA15DPT drastically differs from than that of SBA15DPT  (Fig. 7). The curve 
consists of an abrupt burst release where 100% of the drug is released only after 10 
hours of assay. It can be classified as the Case 1 release model reported by Zeng et 
al.,[44] which corresponds to the fast disassociation of drug molecules from the carrier 
such that koff>>kon. As a result, most of the drug molecules are initially free and the drug 
release profile is determined by diffusion and convection only. In this case, the solution 
in Eq. 6 can be reduced to: 

 = 1 − $
%&'
        (Eq.8) 
The good fit of the experimental data of drug release from HCl-SBA15DPT to Eq. 8 
(R2 = 0.9991) provides a ks value of 1.10 h-1, which is only slightly higher than that of 
SBADPT (0.98 h-1). This could be explained by the greater pore diameter of the former. 
Nonetheless, the lack of steady-state release since almost 100% of CPX is released 
during a burst effect cannot be explained neither considering the chemical nature nor the 
structural and textural properties of HCl-SBA15DPT derived from XRD and N2 
adsorption studies.  
In the search for new insights about possible mesostructural damages that allow 
explaining the different drug release performance of mesoporous matrices, an 
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exhaustive study by HRTEM was carried out. In fact, it is difficult to determine 
alterations in the crystal structures solely from powder XRD data.[47] TEM images and 
their corresponding FT (Fast Fourier Transform) for SBA15DPT and HCl-SBA15DPT 
samples are displayed in Fig. 8 and Fig. 9, respectively. EDS analysis was performed 
during the TEM observation. Si, O and P peaks appear in both samples. The average P 
percentage is 3.6 and 1.7 for SBA15DPT and HCl-SBA15DPT, respectively. Fig. 8 
confirms that SBA15DPT sample exhibits a honeycomb mesoporous arrangement typical 
of SBA-15, in agreement with XRD patterns. However, TEM images of HCl-SBA15DPT 
reveal that there is a noticeable of loss of the mesostructural order (Fig. 9), with only 
small crystalline domains. This mesostructure loss in HCl-SBA15DPT due to the acid 
treatment, which was not detected by XRD, would explain the very different drug 
release profile of this sample. Albeit the extent of mesostructural order does not affect 
drug loading, since as above mentioned acid-treated sample loads higher amounts of 
CPX than untreated sample, it plays a pivotal role in drug release kinetics from 
mesoporous matrices.  
Nonetheless there is another factor that should be also taken into account, since it has 
been reported that mesoporous matrices can undergo degradation when soaked in 
diverse fluids under physiological conditions.[48,49,50] A previous study carried out by 
our research group[49] aimed at comparing the degradation of several SBA-15 type 
mesoporous materials, i.e. pure silica SBA-15 and SBA-15 functionalized with 
alkoxysilanes bearing different organic groups such as aminopropyl, methyl or octyl. 
The results indicated that whereas SBA-15 was partially soluble in all tested media, 
organic modification leaded to the decrease in the degradation rate of mesoporous 
matrices, which was accompanied by preservation of the mesostructural order even after 
60 days of assay. It was concluded that this would be an added value when long-term 
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applications, including drug delivery, are aimed, which require mesoporous matrices 
with stable mesostructural order. However, the influence of mesoporous matrix 
degradation on drug release performance was not evaluated, and it is an interesting topic 
that will be the object of our future investigations.  
Herein, with the aim of supporting the fact that host-guest interactions and 
mesostructural order are the driving factors that govern CPX release profiles, we have 
synthetized pure silica SBA-15, SBA-15 functionalized by co-condensation route using 
an alkoxysilane bearing primary and secondary amine groups (N-(2-aminoethyl)-3-
aminopropyl-trimethoxysilane, DAMO) (affording SBA15DAMO), and a SBA-15 
bifunctionalized by co-condensation using DPT and DAMO (affording SBA15DPT/DAMO) 
(see supplementary material for further detail about the synthetic procedure). Portions 
of these materials were submitted to acidic treatment with 12M HCl under reflux and 
the resulting samples were respectively denoted as HCl-SBA-15, HCl-SBA15DAMO and 
HCl-SBA15DPT/DAMO. Deep characterization of all materials by elemental chemical 
analysis, FTIR and NMR indicated the presence of the corresponding functionalities, 
whereas XRD and N2 adsorption again pointed to well-ordered SBA-15 mesoporous 
structures in all cases. Nonetheless, in a similar fashion than occurred with HCl-
SBA15DPT, HRTEM revealed that the mesostructural order has been notably damaged in 
HCl-treated materials due to the harsh acidic conditions (Figs. S1, S2 and S3).  
All samples, before and after HCl treatment, were loaded with CPX and in vitro release 
tests were performed in PBS (pH 7.4) at 37ºC. Results clearly indicate that the intensity 
of the host-guest interactions govern drug release profiles from samples non-submitted 
to acidic treatment. The slower and incomplete release in the tested time was obtained 
for SBA15DAMO due to the electrostatic attractive interactions between protonated amino 
groups (>NH2+ and –NH3+) and –COO- of CPX at physiological pH (Fig. S2). 
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SBA15DPT/DAMO exhibited the second slower release and also incomplete, by the 
coexistence of attractive (protonated amines of matrix and –COO- of CPX) and 
repulsive forces (–SiO- of the matrix and –COO- of CPX) (Fig. S3). Lastly a sustained 
release when the total amount of drug is released after 350 hours of assay is achieved 
for SBA-15 (Fig. S1), due to the presence of repulsive forces between deprotonated 
silanol groups of the matrix and –COO- of CPX. The different CPX delivery profiles for 
SBA-15 and SBA15DPT could be ascribed to the different extent of degradation of the 
matrices, being greater in the former. This would be in agreement with the above 
mentioned published reports. [49] 
Finally, CPX release assays for all materials submitted to HCl treatment revealed that 
all drug release profiles are similar, obeying an initial burst where 100% of the loaded 
drug is released a few hours of assay for all materials (Figs. S1, S2 and S3).  
All these findings demonstrate that the partial loss of mesostructure, which can be only 
detected by HRTEM, drastically affects drug delivery by promoting the complete drug 
delivery during a fast burst release effect. 
 
4. Conclusions 
Deep characterization of mesoporous materials by HRTEM is indispensable to 
understand their performance as drug delivery devices. This tool becomes of foremost 
relevance to study functionalized mesoporous samples that have to be submitted to 
harsh post-synthesis treatments to attain certain surface organic moieties. This fact has 
been proved by synthetizing a SBA-15-type mesoporous material functionalized with 
ethylphosphonate groups and subsequently treating with concentrated HCl to afford 
ethylphosphonic acid moieties. Although the routine characterization of both materials 
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by XRD and N2 adsorption porosimetry points to well-ordered SBA-15 structures, 
HRTEM studies reveal noticeable mesostructural damage in acid-treated sample. This 
alteration in the mesopores arrangement is not detected by XRD, probably since this 
technique gives average information of the full sample. The mesostructural damage 
dramatically affects drug release profiles from mesopores, giving rise to a fast burst 
effect where 100% of the loaded molecule is released only after 10 hours of in vitro 
assay. This behavior completely differs from that found in the well-ordered untreated 
sample which, despite of exhibiting comparable matrix-drug interactions under the 
release conditions, shows sustained diffusion-controlled drug delivery for more than 2 
weeks. 
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Appendix A. Supplementary material 
Supplementary data related to this article can be found at Microporous and Mesoporous 
Materials website. 
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Tables 
Table 1. Characteristics of the materials synthesized in this work obtained by N2 
adsorption, XRD, XRF and 29Si MAS solid state NMR. 
Sample SBET (m2/g) 
SµP 
(m2/g) 
VT 
(cm3/g) 
VµP 
(cm3/g) 
DP 
(nm) 
a0 
(nm) 
twall 
(nm) 
–(CH2)2P(O)(OX)2 
per nm2 
–SiOH 
per nm2 
SBA15DPT 466 35 0.54 0.0093 7.4 12.3 4.9 1.5 10.6 
HCl-SBA15DPT 364 18 0.55 0.0030 8.7 13.2 4.5 2.5 9.0 
 
SBET and SµP are respectively the surface area determined by using the BET method between the 
relative pressures (P/P0) 0.05-0.25 and micropore surface obtained using the t-plot method. VP 
and VµP are respectively, the total pore volume and micropore volume obtained using the t-plot 
method. The total pore volume was estimated from the amount of N2 adsorbed at a relative 
pressure of 0.97. DP is the pore diameter calculated by means of the BJH method from the 
adsorption branch of the isotherm. a0 is the unit cell parameter calculated by XRD, being 
a0=2/√3.d10. twall is the wall thickness calculated using the equation twall = a0 – DP. The number 
of –(CH2)2P(O)(OX)2 groups per nm2, where X = CH2CH3 and X=H for SBA15DPT and HCl-
SBA15DPT, respectively, was calculated on the basis of XRF. The number of silanol groups 
(SiOH) was determined by single pulse 29Si solid state NMR spectroscopy, as described in the 
experimental section.  
 
Table 2. Peak area (%) of Tm and Qn units from deconvoluting the 29Si MAS NMR 
spectra SBA15DPT and HCl-SBA15DPT samples. Molar functionalization degree, %F = 
100×[Tn/(Tn+Qm)], of samples is also displayed. 
 
 
 
 
Table 3. Kinetic release parameters for cephalexin (CPX) release from SBA15DPT and 
HCl-SBA15DPT materials. 
Sample M0(mg g-1) 
 
koff (×10-3) (h-1) 
 
∆G (×10-21) (J) ks (h-1) R2 
SBA15DPT 21.9 ± 1.0 5.7 ± 0.2 0.30 ± 0.02 0.98 ± 0.05 0.998 
HCl-SBA15DPT 39.0 ± 0.4 ‒ ‒ 1.10 ± 0.03 0.9991 
 
 
 
 
 Peak area (%) of Qn and Tn signals  
Sample T2 T3 Q2 Q3 Q4 %F* 
SBA15DPT 5 10 5 35 45 15 
HCl-SBA15DPT 3 9 3 24 61 12 
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Figure captions 
Scheme 1. Schematic description for the synthesis of SBA15DPT and HCl-SBA15DPT 
samples. 
Figure 1. A) FTIR spectra (4000-2500 cm-1 and 1800-400 cm-1 regions) of SBA15DPT 
and HCl-SBA15DPT samples. B) Magnification of the FTIR spectra in the 1600-1300 
cm-1 region. 
Figure 2. 1H13C CP/MAS solid state NMR spectra of SBA15DPT and HCl-SBA15DPT 
samples 
Figure 3. 29Si MAS and 1H31P CP/MAS NMR spectra of SBA15DPT and HCl-
SBA15DPT samples. The component peaks obtained from spectral deconvolutions are 
displayed by green dotted lines. 
Figure 4. XRD patterns of SBA15DPT and HCl-SBA15DPT samples and indexed 
reflections for the observed peaks. 
Figure 5. A) N2 adsorption-desorption isotherms and pore size distributions of 
SBA15DPT and HCl-SBA15DPT samples. 
Figure 6. Cephalexin (CPX) species and their relative abundance at the pH values of 
6.0 (left) and 7.4 (right), where CPX+, CPX± and CPX– represent the cationic, 
zwitterionic and anionic drug species, respectively.   
Figure 7. Cephalexin (CPX) release profiles at pH 7.4 (phosphate buffer saline, PBS) 
for SBA15DPT and HCl-SBA15DPT samples. Error bars represent the standard deviation 
for three measurements (N = 3) 
Figure 8. (A) TEM image; B) EDS spectra; and C) higher magnification TEM image 
and the corresponding FT (inset) of SBA15DPT sample.  
Figure 9. (A) TEM image; B) EDS spectra; and C) higher magnification TEM image 
and the corresponding FT (inset) of HCl-SBA15DPT sample. 
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Schemes and Figures 
 
Scheme 1 
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Figure 4 
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Figure 5 
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Figure 6 
 
 
Figure 7 
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Figure 8 
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Figure 9 
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Highlights 
1. Treating SBA15DPT with 12M HCl produces -PO3H2 groups but damages the 
mesostructure 
2. HCl-SBA15DPT presents uncontrolled drug burst release compared with SBA15DPT 
3. XRD and N2 adsorption are not enough to detect mesostructural damages in HCl-
SBA15DPT 
4. HRTEM is essential to understand drug release from mesoporous materials 
 
